muscle
N |
• following tamoxifen-treatment, injury-induced myogenesis and satellite cell characteristics are normal
|
• in culture, tamoxifen-treated P0 myoblasts exhibit defective expansive and myogenic potentials compared with control Pax7tm2.1(cre/ERT2)Fan heterozygous myoblasts
• however, myoblasts from tamoxifen-treated adults exhibit normal expansive and myogenic potentials
|
• following tamoxifen treatment between P7 and P11, regeneration is severely compromised compared to in control Pax7tm2.1(cre/ERT2)Fan heterozygotes
• however, following tamoxifen treatment between P14 to P18 and P21 to P25 regeneration capacity gradually increased to levels in control Pax7tm2.1(cre/ERT2)Fan heterozygotes
• following tamoxifen treatment, myofibers continue to be incorporated into a regenerating muscle beyond P31 longer than in control Pax7tm2.1(cre/ERT2)Fan heterozygotes
|